Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Melanoma is added to related topics, MedlinePlus Genetics is linked as a related topic, and a related article by Bautista et al. is cited. These are informational enhancements that do not modify core trial data or user actions on the page.
    Difference
    0.1%
    Check dated 2026-03-14T12:10:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T06:25:37.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed the Melanoma keyword/section and the MedlinePlus Genetics related topics block from the page. This changes the core disease labeling and related topic references displayed.
    Difference
    0.1%
    Check dated 2026-02-28T02:10:13.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics as a related topics reference. Updated the page revision from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T12:42:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Minor metadata update: the page revision tag changed from v3.4.0 to v3.4.1, with no impact on study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:10:57.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Deletions remove the Melanoma topic and a MedlinePlus Genetics related topic from the page, which are minor navigational/contextual items rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T20:22:52.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.